Memories Are Made of This: Recent Advances in Understanding Cognitive Impairments and Dementia
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
“… during the paroxysms of fever, patients are delirious and talk nonsense (desipere et loqui aliena). But insanity is really when a continuous dementia begins, when the patient, although up until then in his senses … (continua dementia ess accepit).” COGNITIVE impairment becomes more common with advancing age. In a study of over 1000 physicians, there was an 18% decline in the total cognitive score between 40 to 70 years of age (1). However, variability within the group was 60% greater in the 70-year-olds compared to the 40-year-olds. Areas in which age-related declines are often more prominent are learning of new information with practice and the speed of motor performance. Cognitive decline represents a major factor involved in the pathogenesis of age-related frailty (2–6) and functional decline (7–12). Intellectual disability is associated negatively with life expectancy (13,14). When a person has had a decline in cognitive dysfunction they become more vulnerable to the development of delirium when they develop physical illnesses. Persons with delirium often present with new-onset falls (15–17), and thus new-onset falls should be considered a delirium equivalent. Delirium is poorly recognized by health care professionals (18) and often has more than one cause (19–21), and, as such, requires the health care physician to carefully evaluate the patient with delirium for multiple possible etiological factors. Persons with delirium often have an elevated circulating level of anticholinergic activity (22). As acetylcholine is an important neurotransmitter involved in the genesis of learning and recall, this suggests that inhibition of acetylcholinergic pathways may be an important end pathway in the pathogenesis of delirium. Many drugs that are not classically considered to be anticholinergic, such as digoxin, theophylline, and amantidine, are highly anticholinergic in in vitro assays (23). This explains why polypharmacy, which remains a major problem in older persons (24,25), is such a potent cause of delirium. Infection produces its cognitive impairment predominantly by the release of cytokines. Cytokines produce cognitive impairment by inhibiting acetylcholine function in the central nervous system, both by directly crossing the blood–brain barrier and by stimulating ascending autonomic nervous system fibers (26,27). The major causes of delirium along with the causes of reversible dementia are listed in Table 1. Recent studies have suggested that an interdisciplinary team focused on delirium (28) or a delirium intensive care unit (29) can greatly improve the outcomes of patients with delirium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · cited 1×
“Vitamin E slows progression of dementia (125).”
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049 · cited 1×
“While classically these persons are not supposed to have depression, recent studies have suggested that neuropsychiatric complaints are not rare in MCI (31).”
BackgroundTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937 · cited 1×
“There is increasing evidence that decreased clearance of beta-amyloid from the central nervous system plays an important role in the pathogenesis of AD (73).”
BackgroundDiscrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
Herholz, K., Salmon, E., Perani, D., Baron, J.-C., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., & Kalbe, E. (2002) · NeuroImage · doi:10.1006/nimg.2002.1208 · Cited by 832
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Self-citationA Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia
Schneider, L. S., Pollock, V. E., & Lyness, S. A. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb02407.x · Cited by 650
Andropause: clinical implications of the decline in serum testosterone levels with aging in men
Matsumoto, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.2.m76 · Cited by 490
Exercise comes of age: rationale and recommendations for a geriatric exercise prescription
Singh, M. A. F. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m262 · Cited by 485
Cited by
Tariq, S. H., Tumosa, N., Chibnall, J. T., Perry, M. H., & Morley, J. E. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000221510.33817.86 · Cited by 724
Self-citationBlood-brain barrier transport of cytokines: a mechanism for neuropathology
Banks, W. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381684 · Cited by 534
“The SAMP8 mouse has a natural mutation so that as it ages, it overexpresses amyloid precursor peptide, has increased brain levels of amyloid beta protein and decreased levels of acetycholine, and develops deficits in learning and memory [24, 55, 57, 58, 100, 101].”
BackgroundSelf-citationRelease of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide
Verma, S., Nakaoke, R., Dohgu, S., & Banks, W. A. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.10.005 · Cited by 265
Self-citationCytokine-Related Aging Process
Morley, J. E., & Baumgartner, R. N. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.9.m924 · Cited by 188
Self-citationDiabetes, Sarcopenia, and Frailty
Morley, J. E. (2008) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2008.03.004 · Cited by 186
Self-citation
Metadata
- Authors
- Banks, W. A., & Morley, J. E.
- Venue
- The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 58
- Issue
- 4
- Pages
- M314-M321
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2102233475
- Cited by
- 58
- References
- 16
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Memories Are Made of This: Recent Advances in Understanding Cognitive Impairments and Dementia. https://app.cochat.ai/papers/10.1093/gerona/58.4.m314
- The paper
- Banks, W. A., & Morley, J. E. (2003). Memories Are Made of This: Recent Advances in Understanding Cognitive Impairments and Dementia. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/58.4.m314
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.